Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has received a consensus rating of "Hold" from the six analysts that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $16.67.
MD has been the topic of several recent analyst reports. Macquarie upped their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Truist Financial cut their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Finally, UBS Group lowered their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th.
Check Out Our Latest Stock Report on MD
Pediatrix Medical Group Price Performance
MD traded up $0.41 during midday trading on Tuesday, hitting $14.04. 1,002,546 shares of the company traded hands, compared to its average volume of 749,920. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a current ratio of 1.81, a quick ratio of 1.81 and a debt-to-equity ratio of 0.75. The business has a 50 day simple moving average of $13.69 and a two-hundred day simple moving average of $13.91. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of -13.90, a PEG ratio of 0.92 and a beta of 1.27.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The business had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. During the same quarter in the prior year, the firm earned $0.20 earnings per share. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. On average, equities analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.
Institutional Trading of Pediatrix Medical Group
A number of large investors have recently modified their holdings of MD. California State Teachers Retirement System lifted its stake in Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after acquiring an additional 752 shares during the last quarter. AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. SummerHaven Investment Management LLC lifted its position in shares of Pediatrix Medical Group by 0.9% during the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after purchasing an additional 1,028 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its stake in shares of Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.
About Pediatrix Medical Group
(
Get Free ReportPediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Further Reading
Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
